This market will resolve to "Yes" if Johnson & Johnson's MedTech revenue for the upcoming second fiscal quarter, as reported in its official company earnings materials, is above the listed amount. Otherwise, this market will resolve to "No".
The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered.
If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to "No".
If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to "No".
If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market.
The resolution source for this market is Johnson & Johnson's official company earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used.
Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.
$8.8B
$183 Volume
90%
$8.9B
$1.8K Volume
74%
$9B
$2.4K Volume
57%
$9.1B
$3.4K Volume
50%
$9.2B
$1.8K Volume
24%
Odds & FAQ
What are the current odds for Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above __?
At 88%, $8.8B has pulled far clear of $8.9B (68%). Prices stay live until resolution, but the market sees one clear outcome.
What do traders predict for Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above __?
With 88% implied for $8.8B, the market has largely made up its mind. Still a forecast, not a result: prices react instantly if the story changes.
When does the Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above __ market resolve?
Resolution is scheduled for 15 Jul 2026 (4 days left). Once the outcome is confirmed, the market settles under Polymarket's published criteria.
How much money is trading on Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above __?
$9.6K in total volume has traded here. Deeper markets like this tend to price events more sharply.
How can I trade Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above __ on Polymarket?
Track the live odds on this page, then open the market on Polymarket to take a position. Trade carefully - only stake what you can afford to lose.
Similar Markets
2%-4%42%YesNo
4%+34%YesNo
85%-86%45%YesNo
86%+26%YesNo
32%-34%78%YesNo
34%-36%12%YesNo
86%-89%71%YesNo
<86%26%YesNo
15%-17.5%65%YesNo
12.5%-15%24%YesNo
<3.5%45%YesNo
4.5%-5.5%27%YesNo
19¢-19.5¢64%YesNo
19.5¢+35%YesNo
